Handheld device for counterfeit drug detection to be tested in AfricaBMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f2732 (Published 26 April 2013) Cite this as: BMJ 2013;346:f2732
- Michael McCarthy
The United States’ Food and Drug Administration (FDA) will begin testing a handheld device to detect counterfeit and substandard malaria drugs in Africa this year, the agency has said.
The battery operated device, CD-3, detects counterfeit and substandard products by illuminating them with a variety of wavelengths of light, ranging from ultraviolet to infrared. When placed side by side under the light and viewed through the device’s camera system, the authentic and …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial